NovaBridge Biosciences director Martin William Dewhurst files initial beneficial ownership statement
NBP•Initial Form 3 filing
NovaBridge Biosciences director Martin William Dewhurst filed an initial Form 3 on Sept. 10 covering holdings as of Sept. 8.
